Medicalized Female Genital Mutilation/Cutting: Contentious Practices and Persistent Debates (2018)
This study is a Exploratory research regarding All FGM/C with the following characteristics:
Author(s): Kimani,S. & Shell-Duncan,B.
FGM/C Type(s): All
Health area of focus: None.
Objective: This study summarized key debates and critically assessed supporting evidence.
Study Population: Relied on DHS nad MICS
Findings: Most medicalization happens in Africa,but health professionals all over the world have been asked to perform FGM/C. It’s not clear if medicalization is slowing down the decline of FGM/C or not. Safety concerns are one reason for medicalization,but they aren’t the only one. By getting health professionals involved in the fight to end FGM/C,both the supply and demand sides of medicalization can be addressed. However,this raises ethical concerns about having dual loyalty. During ongoing debates,different rights claims need to be dealt with. Summary debates that divide people haven’t led to much progress. There is need for everyone to work toward the same goals of protecting the health and well-being of girls who live in places where FGM/C is still practiced,and more open and informed conversation is encouraged.
Geographical coverage
Region(s):Western Africa,Eastern Africa,Middle Africa,Western Asia,Northern Africa
Country(ies):Benin,Burkina Faso,Cameroon,Central African Republic,Chad,Côte d’Ivoire,Djibouti,Egypt,Eritrea,Gambia,Ghana,Guinea,Guinea-Bissau,Iraq,Kenya,Mali,Mauritania,Niger,Nigeria,Senegal,Sierra Leone,Sudan,Togo,Tanzania,Yemen